CYRX Cryoport Inc

Price (delayed)

$17.47

Market cap

$855.64M

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$2.21

Enterprise value

$1.22B

Cryoport, Inc. is redefining temperature-controlled supply chain support for the life sciences industry by continually broadening its platform of solutions, serving the Biopharma, Reproductive Medicine, and Animal Health markets. Through ...

Highlights
The debt has decreased by 4.6% YoY
The company's net income has shrunk by 167% YoY and by 114% QoQ
Cryoport's EPS has plunged by 138% YoY and by 96% from the previous quarter

Key stats

What are the main financial stats of CYRX
Market
Shares outstanding
48.98M
Market cap
$855.64M
Enterprise value
$1.22B
Valuations
Price to earnings (P/E)
N/A
Price to book (P/B)
1.75
Price to sales (P/S)
3.65
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
5.25
Earnings
Revenue
$233.26M
EBIT
-$93.85M
EBITDA
-$61.26M
Free cash flow
-$44.79M
Per share
EPS
-$2.21
Free cash flow per share
-$0.92
Book value per share
$9.99
Revenue per share
$4.79
TBVPS
$13.44
Balance sheet
Total assets
$957.74M
Total liabilities
$468.72M
Debt
$416M
Equity
$489.02M
Working capital
$489.5M
Liquidity
Debt to equity
0.85
Current ratio
11.73
Quick ratio
10.97
Net debt/EBITDA
-6.01
Margins
EBITDA margin
-26.3%
Gross margin
42.6%
Net margin
-42.7%
Operating margin
-49.4%
Efficiency
Return on assets
-10.7%
Return on equity
-20.2%
Return on invested capital
-9.3%
Return on capital employed
-10.3%
Return on sales
-40.2%
Dividend
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A

CYRX stock price

How has the Cryoport stock price performed over time
Intraday
-3.27%
1 week
-4.06%
1 month
7.18%
1 year
-13.81%
YTD
12.78%
QTD
-1.3%

Financial performance

How have Cryoport's revenue and profit performed over time
Revenue
$233.26M
Gross profit
$99.33M
Operating income
-$115.16M
Net income
-$99.59M
Gross margin
42.6%
Net margin
-42.7%
The net margin has plunged by 172% YoY and by 117% from the previous quarter
The company's net income has shrunk by 167% YoY and by 114% QoQ
Cryoport's operating margin has shrunk by 108% QoQ
Cryoport's operating income has plunged by 104% from the previous quarter

Growth

What is Cryoport's growth rate over time

Valuation

What is Cryoport stock price valuation
P/E
N/A
P/B
1.75
P/S
3.65
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
5.25
Cryoport's EPS has plunged by 138% YoY and by 96% from the previous quarter
CYRX's price to book (P/B) is 58% less than its 5-year quarterly average of 4.3 but 13% more than its last 4 quarters average of 1.6
Cryoport's equity has decreased by 12% YoY and by 9% from the previous quarter
CYRX's P/S is 74% below its 5-year quarterly average of 14.4 but 4.7% above its last 4 quarters average of 3.6

Efficiency

How efficient is Cryoport business performance
CYRX's return on equity has dropped by 156% year-on-year and by 104% since the previous quarter
Cryoport's ROS has plunged by 151% from the previous quarter
The company's return on invested capital has shrunk by 151% QoQ
The return on assets has dropped by 149% year-on-year and by 102% since the previous quarter

Dividends

What is CYRX's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for CYRX.

Financial health

How did Cryoport financials performed over time
The total assets is 104% more than the total liabilities
The current ratio has contracted by 21% YoY and by 4.1% from the previous quarter
The quick ratio has declined by 21% year-on-year and by 3.4% since the previous quarter
The debt is 15% less than the equity
Cryoport's equity has decreased by 12% YoY and by 9% from the previous quarter
The debt to equity is up by 10% since the previous quarter and by 9% year-on-year

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.